Literature DB >> 12107169

Regulation of Fas-associated death domain interactions by the death effector domain identified by a modified reverse two-hybrid screen.

Lance R Thomas1, David J Stillman, Andrew Thorburn.   

Abstract

The adapter protein FADD consists of two protein interaction domains and is an essential component of the death inducing signaling complex (DISC) that is formed by activated death receptors of the tumor necrosis factor (TNF) receptor family. The FADD death domain binds to activated receptors such as Fas or other adapters such as TRADD, whereas the FADD death effector domain binds to procaspase 8. Each domain can interact with its target in the absence of the other domain, and this has led to the idea that the two domains function independently. FADD death domain interactions with Fas and TRADD are thought to occur on the same surface; however, the regulation of these interactions is poorly understood. We developed a modified reverse two-hybrid method that can identify mutations, which inhibit some protein-protein interactions without affecting other interactions. Using this method, we identified mutations in FADD that prevent binding to Fas but do not affect binding to TRADD. Surprisingly, these mutations were in the death effector domain rather than the death domain. To test whether the mutants function in mammalian cells, we expressed wild type or mutant FADD molecules in FADD-deficient cells. Wild type FADD rescued both Fas ligand- and TNF-dependent signaling, whereas the FADD death effector domain mutants rescued only TNF signaling. These data indicate that in contrast to current models, the death effector domain of FADD is involved in interaction with Fas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107169     DOI: 10.1074/jbc.M204169200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress.

Authors:  Sathish Kumar Natarajan; Donald F Becker
Journal:  Cell Health Cytoskelet       Date:  2012-02-01

2.  A family of human zinc finger proteins that bind methylated DNA and repress transcription.

Authors:  Guillaume J P Filion; Svetlana Zhenilo; Sergey Salozhin; Daisuke Yamada; Egor Prokhortchouk; Pierre-Antoine Defossez
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

3.  Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain.

Authors:  Justine M Hill; Hema Vaidyanathan; Joe W Ramos; Mark H Ginsberg; Milton H Werner
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

4.  Fas-associated protein with death domain (FADD)-independent recruitment of c-FLIPL to death receptor 5.

Authors:  Tai-Guang Jin; Alexei Kurakin; Nordine Benhaga; Karon Abe; Mehrdad Mohseni; Ferry Sandra; Keli Song; Brian K Kay; Roya Khosravi-Far
Journal:  J Biol Chem       Date:  2004-10-14       Impact factor: 5.157

5.  Caspase- and serine protease-dependent apoptosis by the death domain of FADD in normal epithelial cells.

Authors:  Jacqueline Thorburn; Laura M Bender; Michael J Morgan; Andrew Thorburn
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

6.  Drosophila IAP antagonists form multimeric complexes to promote cell death.

Authors:  Cristinel Sandu; Hyung Don Ryoo; Hermann Steller
Journal:  J Cell Biol       Date:  2010-09-13       Impact factor: 10.539

7.  Understanding the conservation patterns and molecular phylogenetics of human death receptors family through computational biology.

Authors:  Jinny Tomar; Chiranjib Chakraborty; C George Priya Doss; V K Gera
Journal:  3 Biotech       Date:  2013-05-25       Impact factor: 2.406

8.  Benzene-poly-carboxylic acid complex, a novel anti-cancer agent induces apoptosis in human breast cancer cells.

Authors:  Fuad Fares; Naiel Azzam; Basem Fares; Stig Larsen; Steen Lindkaer-Jensen
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

9.  A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosis.

Authors:  Luke M Humphreys; Jennifer P Fox; Catherine A Higgins; Joanna Majkut; Tamas Sessler; Kirsty McLaughlin; Christopher McCann; Jamie Z Roberts; Nyree T Crawford; Simon S McDade; Christopher J Scott; Timothy Harrison; Daniel B Longley
Journal:  EMBO Rep       Date:  2020-02-03       Impact factor: 9.071

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.